Immunovia Set To Launch PancreaSure In U.S.
ReutersAug 19, 2025 8:42 AM
Aug 19 (Reuters) - Immunovia AB (publ) IMMNOV.ST:
IMMUNOVIA SET TO LAUNCH PANCREASURE IN THE US ON SEPTEMBER 2ND, SHARES COMMERCIAL STRATEGY
PANCREASURE TEST IS SET TO LAUNCH IN US ON SEPTEMBER 2ND
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
Circle’s Next Chapter: Not Just Stablecoins, But a Payments Network
TradingKey - Stablecoins are meeting real-world demand, especially in emerging markets where payment systems are oftenfragmented, access to the traditional banking system is limited, or capital controls restrict seamless global flows.TradingKey
13 hours ago
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks aheadTradingKey
Thu, Sep 4
U.S. July CPI Commentary: Obstacles Cleared, Where Will U.S. Stocks Go Next?
TradingKey - On 12 August 2025, the United States released its Consumer Price Index (CPI) data for July. In terms of headline inflation, the CPI rose by 2.7% year-on-year in the month, slightly lower than the expected 2.8%. However, core CPI climbed 3.1% year-on-year, edging past the projected 3.0%.TradingKey
Wed, Aug 13
Tradingkey
